BioCatalyst

Mirvetuximab Soravtansine, Lubricating Eye Drops, Prednisolone acetate ophthalmic suspension 1% eye drops, Brimonidine tartrate ophthalmic solution eye drops — catalyst calendar

1 verified catalyst event(s) referencing Mirvetuximab Soravtansine, Lubricating Eye Drops, Prednisolone acetate ophthalmic suspension 1% eye drops, Brimonidine tartrate ophthalmic solution eye drops, each linked to its official source. Verified as of 2026-10-03.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-02 (month)
in 4mo
ESTIMATED
 READOUT
A Study of Ocular Toxicity Evaluation and Mitigation During Treatment With Mirve
Phase 2 · Recurrent Ovarian Cancer, Folate Receptor-Alpha Positive
 ABBV AbbVie Inc. Mirvetuximab Soravtansine, Lubricating E ClinicalTrials.gov ↗
✓ Source-checked 2026-10-03
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.